Skip to main content

Advertisement

Log in

Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

A treat to target (T2T) approach to management has become the standard of care for patients with rheumatoid arthritis (RA). While consensus T2T recommendations call for patient involvement in the treatment process, the targets commonly used to drive therapeutic decisions involve limited patient input. A pilot study was developed to explore whether the Patient-Reported Outcomes Measurement Information System (PROMIS) could add value to the T2T approach by providing a way to bring patient goals into the process. We report here the baseline data from this study. RA patients from an academic rheumatology practice were recruited to participate in this 1-year study. Patients were asked to complete PROMIS computer-assisted testing at quarterly visits during the year. At baseline, they were asked to identify the PROMIS domain (Pain Interference, Fatigue, Depression, Physical Function, and Social Function) that felt most important to their quality of life. They were then asked to select five representative items from this domain, to be followed through the year. Complete baseline data was available for 119 patients. Most selected Physical Function (39%) or Pain Interference (37%) as their highest priority PROMIS domain. Sixty percent ranked Depression as their lowest priority domain. Younger patients more frequently prioritized Social Function, while older patients more frequently prioritized Fatigue. The incorporation of PROMIS questionnaires into routine clinic visits is a feasible mechanism for incorporating patient preferences into a T2T approach to managing RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Smolen JS, Aletaha D, Bijlsma JW et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mitchell DM, Spitz PW, Young DY et al (1986) Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis Rheum 29:706–715

    Article  CAS  PubMed  Google Scholar 

  3. Scholes M, Aletaha D, Smolen JS et al (2010) Follow-up standards and treatment targets in rheumatoid arthritis (RA): results of a questionnaire at the EULAR 2008. Ann Rheum Dis 69:575–578

    Article  Google Scholar 

  4. Schoels M, Wong J, Scott DL, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 2010; in press

  5. Emery P, Salmon M (1995) Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 54:944–947

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jurgens MS, Welsing PM, Jacobs JW (2012) Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission. Clin Exp Rheumatol 30(4 Suppl 73):S56–S63

    PubMed  Google Scholar 

  7. Schipper LG, Vermeer M, Kuper HH et al (2012) A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch rheumatoid arthritis monitoring registry. Ann Rheum Dis 71(6):845–850

    Article  CAS  PubMed  Google Scholar 

  8. Vermeer M, Kuper HH, Bernelot Moens HJ et al (2012) Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort. Arthritis Res Ther 14(6):R254

    Article  PubMed  PubMed Central  Google Scholar 

  9. de Wit MP, Smolen JS, Gossec L, van der Heijde DM (Jun 2011) Treating rheumatoid arthritis to target: the patient version of the international recommendations. Ann Rheum Dis 70(6):891–895

    Article  PubMed  PubMed Central  Google Scholar 

  10. Castrejon I, Pincus T Patient self-report outcomes to guide a treate-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis. Clin Exp Rheumatol 30(4 Suppl.73):S50–S55

  11. Mathews A, Coleska A, Burns P et al (2016) Evolution of patient decision-making regarding medical treatment of rheumatoid arthritis. Arthritis Care Res 68(3):318–324

    Article  Google Scholar 

  12. Steunebrink L, Vonkeman H, Kooster P et al (2016) Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry. Clin Rheumatol 35:609–615

    Article  PubMed  PubMed Central  Google Scholar 

  13. Almoallim H, Kamil A (2013) Rheumatoid arthritis: should we shift the focus from “treat to target” to “treat to work?”. Clinical rheumatology 32(3):285–287

    Article  PubMed  Google Scholar 

  14. Pincus T, Castrejon I, Bergman MJ, Yazici Y (2012) Treat-to-target: not as simple as it appears. Clin Exp Rheumatol 30(4 Suppl 73):S10–S20

    PubMed  Google Scholar 

  15. Peipert J, Beaumont J, Bode R et al (2014) Development and validation of the functional assessment of chronic illness therapy treatment satisfaction (FACIT TS) measures. Qual Life Res 23(3):815–824

    Article  PubMed  Google Scholar 

  16. Bartlett S, Orbai A, Duncan T, et al. (2013) Validity of PROMIS CATS, short forms and global health items in rheumatoid arthritis. Qual Life Res 22 (supp 1)

  17. HealthMeasures (2015). PROMIS ®http://www.healthmeasures.net/score-and-interpret/interpret-scores/promis

  18. Matcham F, Rayner L, Steer S et al (2013) The prevelance of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 52(12):2136–2148

    Article  PubMed  PubMed Central  Google Scholar 

  19. Attar S (2014) Can we predict depression in patients with rheumatoid arthritis. Kuwait Med J 46(3):219–224

    Google Scholar 

  20. Robinson SM, Walker DJ (Feb 2012) Negotiating targets with patients: choice of target in relation to occupational state. Rheumatology (Oxford) 51(2):293–296

    Article  Google Scholar 

  21. van Hulst LT, Kievit W, van Bommel R, van Riel PL, Fraenkel L (2011) Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment. Arthritis Care Res 63(10):1407–1414

    Article  Google Scholar 

  22. DeWalt DA, Rothrock N, Yount S, Stone AA (2007) Evaluation of item candidates: the PROMIS qualitative item review. Med Care 45(5 Suppl 1):S12–S21

    Article  PubMed  PubMed Central  Google Scholar 

  23. Fries JF, Cella D, Rose M, Krishnan E, Bruce B (2009) Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol 36(9):2061–2066

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This research was funded by an unrestricted educational grant from Pfizer (PIs Cella and Ruderman). The content is solely the responsibility of the authors and does not necessarily represent the views of the funding agency. Additional grant support provided by NIAMS P60-AR064464.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric M. Ruderman.

Ethics declarations

Disclosures

D Cella and EM Ruderman have received compensation from Pfizer for consulting work unrelated to this study. AM Mandelin has received compensation as a member of Pfizer’s speakers’ bureau. The other authors have disclosed no conflicts of interest.

Additional information

Key message

PROMIS questionnaires provide a feasible mechanism for incorporating patient preferences into the management of RA.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bacalao, E., Greene, G.J., Beaumont, J.L. et al. Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities. Clin Rheumatol 36, 1729–1736 (2017). https://doi.org/10.1007/s10067-017-3731-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3731-5

Keywords

Navigation